|
|
|
|
|
|
|
|
|
|
Abstract
Summary
Tumour lysis syndrome is a
potentially life-threatening oncological emergency most commonly
encountered in patients with rapidly
proliferating, treatment-responsive
haematological malignancies. It is rarely observed in solid tumours and,
to our knowledge,
this is the first time that it has been
reported in a cancer with an intravascular tumour extension. In this
report, we describe
a case of a woman who presented with
recurrent ovarian cancer and was found to have tumour invading into her
vasculature.
The patient subsequently developed
tumour lysis syndrome after receiving chemotherapy. The case highlights
the importance
of considering tumour lysis syndrome
prophylaxis when treating patients with intravascular involvement from a
solid malignancy
even if, as in this case, it is a
recurrent tumour. Included is a brief review of the literature. We
propose that ‘intravascular
tumour invasion is recognised as an
important risk factor for the development of tumour lysis syndrome.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.